Myocarditis and Pericarditis after mRNA COVID-19 Vaccination: Status and Management Update

Since concerns emerged about rare cases of myocarditis and pericarditis following mRNA COVID-19 vaccines in 2021, researchers have underscored the importance of standardizing diagnostic criteria and evaluation of incident cases. This webinar will provide a status and clinical management update on post-vaccine myocarditis and pericarditis from public health, cardiology, and family medicine perspectives.

Program Chair: Anil Gupta MD

Faculty: Dalsy de la cruz davalos MD, Nathaniel Hawkins MBChB MD MPH, Tahir Kafil MD, Alexander Singer MD, Tonja Stothart MD

By the end of the session, the participant will be able to:

1. Describe the adverse event following the immunization (AEFI) reporting and evaluation process.
2. Report the incidence of post-vaccine myocarditis and pericarditis in Canada.
3. Recognize the clinical presentation of post-vaccine myocarditis and pericarditis.
4. Apply clinical guidance to the evaluation, management, and follow-up of patients with post-vaccine myocarditis and pericarditis.
5. Access new CCS tools about this topic and integrate them into their practice.

Inscrivez-vous Opens in a new window